Skip to content
Medical Health Aged Care

New clues in understanding faster disease progression in multiple sclerosis

The Florey 2 mins read

Florey scientists help identify the first genetic marker for multiple sclerosis (MS) severity, opening the door to preventing long-term disability.

Melbourne scientists have joined MS researchers from around the world by contributing to a study that has identified genetic factors influencing outcomes in people with MS.

The study of more than 22,000 people with MS has discovered the first genetic variant associated with faster disease progression, which can rob patients of their mobility and independence over time.

MS is the result of the immune system mistakenly attacking the brain and the spinal cord, resulting in symptom flare-ups known as relapses, as well as longer-term degeneration known as progression. Despite the development of effective treatments for relapses, none can reliably prevent the accumulation of disability.

The findings, published today in Nature, point to a genetic variant that increases disease severity, providing the first real progress in understanding and eventually fighting this aspect of MS.

The Florey’s Neurogenetics Group Head, Associate Professor Justin Rubio, said the team in Melbourne provided the study with clinical data and DNA samples from people in Victoria living with MS.

“We don’t understand why the rate of disability accumulation in people with MS is so variable, leaving some using a wheelchair after 10 years and others running marathons,” said Associate Professor Rubio, Chair of the ANZgene MS Genetics Consortium.

“By identifying these genetic variants, we’re demonstrating that genes expressed in the nervous system are important modifiers of MS outcome, which opens the door for new treatments for MS progression,” he said.

The Nature study, which analysed samples from North America, Europe and Australia, involved more than 70 institutions and was led by researchers from the University of California San Francisco (UCSF) and the University of Cambridge.

The Florey leads important MS research in Australia, with projects underway to understand the role of nervous system repair in MS progression; to find novel therapies; and to discover early detection methods and treatment options.

"MS is the most common neurodegenerative disease in young adults. This discovery provides an important new piece in the puzzle that could lead to the development of new treatment options for people with MS,” Associate Professor Rubio said.


Notes to editor:

  1. This work was supported in part by funding from the NIH/NINDS (R01NS099240), the European Union’s Horizon 2020 Research and Innovation Funding Programme, and the Multiple Sclerosis Society of Canada.



About us:

The Florey is Australia’s leading brain research institute with a focus on improving the lives of people with neurological and psychiatric conditions. The Florey’s research missions are centred around dementia, epilepsy, mental health and developing ways to protect and repair the brain. These missions are strengthened by The Florey’s expertise in neurotherapeutics, neuroimaging, synaptic biology and systems neuroscience. With 600 staff, The Florey is the largest research centre of its kind in the southern hemisphere.

Find out more about us on our website:

Contact details:

Kathryn Powley

Media and Communications Manager

The Florey

0456 666 271

More from this category

  • Medical Health Aged Care
  • 11/12/2023
  • 12:27
Royal Australian College of GPs

RACGP thanks Queensland Premier for her service

The Royal Australian College of GPs (RACGP) has thanked Queensland Premier Annastacia Palaszczuk for her service to the state of Queensland. Ms Palaszczuk announced her retirement at a press conference yesterday, she will step down as premier at the end of the week, and as the member for Inala at the end of the year. RACGP President and Mackay-based GP Dr Nicole Higgins thanked Premier Palaszczuk. “On behalf of GPs and practice teams across the state that we both love, I thank Premier Palaszczuk for her leadership and wish her all the best for whatever comes next,” she said. “Her…

  • CharitiesAidWelfare, Medical Health Aged Care
  • 11/12/2023
  • 11:42
National Rural Health Alliance

Rural voices heard in government’s health reform review

The National Rural Health Alliance (the Alliance) is pleased to see the release of the Final Report of the Mid-Term Review of the National…

  • Contains:
  • Medical Health Aged Care
  • 11/12/2023
  • 10:45
Royal Australian College of GPs

Health reform report welcome, but primary care must remain focus for future investment and reform

The Royal Australian College of GPs (RACGP) has welcomed the final report of the Mid-Term Review of the National Health Reform Agreement (NHRA) Addendum 2020-2025, but warned the Government against compromising quality care. The NHRA is an agreement between the Federal Government and all state and territory governments to improve health outcomes by coordinating care and ensuring the future sustainability of Australia’s health system. It forms the basis for federal funding contributions to states and territories for public hospitals and provides mechanisms to improve coordination between general practice, hospitals, and other parts of the health system. In its submission, the…

  • Contains:

Media Outreach made fast, easy, simple.

Feature your press release on Medianet's News Hub every time your distribute with Medianet. Pay per release or save with a subscription.